|
|
Volumn 154, Issue 17, 1994, Pages 1945-1953
|
|
Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
PROTHROMBIN;
WARFARIN;
AGED;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
HEALTH MAINTENANCE ORGANIZATION;
HEART ATRIUM FIBRILLATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROTHROMBIN TIME;
STROKE;
AGED;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
CEREBROVASCULAR DISORDERS;
CLINICAL TRIALS;
COMPARATIVE STUDY;
DIABETES MELLITUS;
FEMALE;
HEALTH MAINTENANCE ORGANIZATIONS;
HUMAN;
HYPERTENSION;
MALE;
PHYSICIAN'S PRACTICE PATTERNS;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIALS;
RISK;
SUPPORT, NON-U.S. GOV'T;
TREATMENT OUTCOME;
WARFARIN;
|
|
EID: 0027965628
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.154.17.1945 Document Type: Article |
|
Times cited : (226)
|
|
References (53)
|
